Alerts will be sent to your verified email
Verify Email
MERCURYLAB
|
Mercury Laboratories
|
Aptus Pharma
|
Mangalam Drugs&Org.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.51 % | 36.58 % | -0.44 % |
|
5yr average Equity Multiplier
|
1.49 | 5.05 | 2.43 |
|
5yr Average Asset Turnover Ratio
|
1.05 | 1.72 | 1.0 |
|
5yr Avg Net Profit Margin
|
6.6 % | 6.16 % | 0.0 |
|
Price to Book
|
1.83 | 14.36 | 0.66 |
|
P/E
|
20.71 | 32.31 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-4.69 Days | 88.73 Days | 17.41 Days |
|
Inventory Days
|
32.68 Days | 64.83 Days | 132.58 Days |
|
Days Receivable
|
115.65 Days | 65.8 Days | 38.43 Days |
|
Days Payable
|
157.73 Days | 77.01 Days | 126.53 Days |
|
5yr Average Interest Coverage Ratio
|
15.15 | 6.23 | 0.9 |
|
5yr Avg ROCE
|
13.49 % | 28.46 % | 6.92 % |
|
5yr Avg Operating Profit Margin
|
11.74 % | 10.95 % | 7.63 % |
|
5 yr average Debt to Equity
|
0.13 | 2.26 | 0.59 |
|
5yr CAGR Net Profit
|
-10.08 % | 74.79 % | 39.54 % |
|
5yr Average Return on Assets
|
7.02 % | 8.44 % | -0.18 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.66 % | 72.89 % | 50.3 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 34.58 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Mercury Laboratories
|
Aptus Pharma
|
Mangalam Drugs&Org.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|